Overview
Karen Eustace practices in Dublin, Ireland. Ms. Eustace is rated as an Advanced expert by MediFind in the treatment of Hypersensitivity Vasculitis. Her top areas of expertise are Hypersensitivity Vasculitis, Pityriasis Lichenoides Chronica, Pityriasis Lichenoides, and Pityriasis Lichenoides Et Varioliformis Acuta.
Her clinical research consists of co-authoring 34 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Hypersensitivity Vasculitis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Hypersensitivity VasculitisMs. Eustace isAdvanced. Learn about Hypersensitivity Vasculitis.
- Pityriasis LichenoidesMs. Eustace isAdvanced. Learn about Pityriasis Lichenoides.
- Pityriasis Lichenoides ChronicaMs. Eustace isAdvanced. Learn about Pityriasis Lichenoides Chronica.
- Pityriasis Lichenoides Et Varioliformis Acuta
- Experienced
- Atopic DermatitisMs. Eustace isExperienced. Learn about Atopic Dermatitis.
- BullaeMs. Eustace isExperienced. Learn about Bullae.
- Cold UrticariaMs. Eustace isExperienced. Learn about Cold Urticaria.
- Contact DermatitisMs. Eustace isExperienced. Learn about Contact Dermatitis.
- Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome)
- ErythrodermaMs. Eustace isExperienced. Learn about Erythroderma.